Emily Tjeuw|Michael J Wonder - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

International Journal of Technology Assessment in Health Care|February 4, 2022

Analysis of consumer comments into PBAC decision-making (2014-9)Emily Tjeuw, Michael J Wonder

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 15, 2006

Are Australians able to access new medicines on the pharmaceutical benefits scheme in a more or less timely manner? An analysis of pharmaceutical benefits advisory committee recommendations, 1999-2003Michael J Wonder, A Munro Neville, Richard Parsons

Leukemia & Lymphoma|July 15, 2006

Development of a predictive population survival model according to the cytogenetic response rate for patients with chronic myeloid leukemia in the chronic phaseRudolf J Schrover, Michael A Adena, Richard De Abreu Lourenco, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

International Journal of Technology Assessment in Health Care|February 4, 2022

Analysis of consumer comments into PBAC decision-making (2014-9)Emily Tjeuw, Michael J Wonder

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 15, 2006

Are Australians able to access new medicines on the pharmaceutical benefits scheme in a more or less timely manner? An analysis of pharmaceutical benefits advisory committee recommendations, 1999-2003Michael J Wonder, A Munro Neville, Richard Parsons

Leukemia & Lymphoma|July 15, 2006

Development of a predictive population survival model according to the cytogenetic response rate for patients with chronic myeloid leukemia in the chronic phaseRudolf J Schrover, Michael A Adena, Richard De Abreu Lourenco, et al.

Pageof 1